Showing 20 of 28 recruiting trials for “chronic-relapsing-inflammatory-optic-neuritis”
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
RecruitingNCT07273903 ↗
Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices
👨⚕️ Marc G Pawlitzki, PD Dr. med., Department of Neurology, Heinrich-Heine University, and University Hospital Duesseldorf, Germany📍 2 sites📅 Started Jan 2026View details ↗
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
RecruitingNCT07154524 ↗
Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
RecruitingNCT07264426 ↗
Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
RecruitingNCT06538064 ↗
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Safety, Tolerability, and Efficacy of NVG-2089 in Participants With CIDP
RecruitingNCT06968975 ↗
Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
🏥 Amsterdam University Medical Center (UMC), Location Academic Medical Center (AMC)📍 1 site📅 Started Oct 2024View details ↗
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →